In-air microfluidics produces 3D printed structures of living cells1 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Scientists have succeeded in printing 3D structures with living cells, this enables the production of micro building blocks that are viable and can be used for repairing damaged tissue...
Tofacitinib-UV B light therapy combination restores skin colour in vitiligo1 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Researchers have successfully applied a novel combination therapy to restore skin colour in patients with vitiligo...
Cancer vaccine eliminates tumours1 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
NIH partnership to improve clinical trials for Parkinson’s disease31 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)The NIH is teaming with the government, biopharmaceutical, life science and non-profit organisations to overcome obstacles and increase success for advancing promising treatments for PD...
Microbubbles make breast cancer more susceptible to radiation therapy31 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Bursting oxygen-filled microbubbles in breast cancer makes tumours three times more sensitive to radiation therapy in preliminary tests with animal models of the disease...
Study reveals huge improvement for severe HHT patients after bevacizumab treatment31 January 2018 | By European Pharmaceutical ReviewA new study reveals the efficacy and safety of using intravenous bevacizumab to treat patients with severe hereditary haemorrhagic telangiectasia (HHT). Successful results suggest it should be used as a first-line therapy.
New approach identifies existing leukaemia drugs that show promise for Ewing sarcoma treatment31 January 2018 | By European Pharmaceutical ReviewScientists in the United States have discovered that two existing FDA-approved drugs, clofarabine (Clolar™) and cladribine (Leustatin™), have a powerful inhibitory impact on Ewing sarcoma cells in the lab.
Researchers develop wireless light switch for targeted cancer therapy30 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)A team of scientist have developed a way to wirelessly deliver light into deep regions of the body to activate light-sensitive drugs for photodynamic therapy...
Are you using the right micropipette?30 January 2018 | By INTEGRA BiosciencesINTEGRA Biosciences is helping researchers to improve pipetting efficiency and ensure reliable results with a recently published guide to choosing the right micropipette...
Zika vaccine candidate receives FDA fast track designation30 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)The FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate...
Pyridostigmine reverses paediatric complications of botulinum toxin therapy30 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...
Patients must get the medicine they need after Brexit29 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Patients could find that supplies of their medicines will be disrupted when the UK leaves the EU, according to a new briefing published by the Brexit Health Alliance...
FDA approves Lutathera for somatostatin receptor-positive GEP-NETs29 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)The FDA has approved Lutathera for the treatment of a type of cancer that affects the pancreas the gastrointestinal tract...
Tecan to launch Fluent® Gx Automation Workstation for use in regulated laboratories29 January 2018 | By TecanTecan’s range of advanced liquid handling solutions will soon be enhanced with the introduction of the new Fluent® Gx Automation Workstation*, designed specifically to meet the stringent needs of clinical and regulated laboratories...
Enzyme replacement therapy to treat alpha-mannosidosis29 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis...
